Operating Lease, Right-of-Use Asset in USD of Lantern Pharma Inc. from Q2 2021 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Lantern Pharma Inc. quarterly Operating Lease, Right-of-Use Asset history and change rate from Q2 2021 to Q3 2025.
  • Lantern Pharma Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $93,090, a 68% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Lantern Pharma Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $93,090 -$193,545 -68% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $143,240 -$69,805 -33% 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 $192,196 +$4,985 +2.7% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 $239,985 +$11,690 +5.1% 31 Dec 2024 10-Q 12 Nov 2025 2025 Q3
Q3 2024 $286,635 +$17,998 +6.7% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $213,045 -$95,206 -31% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $187,211 -$68,109 -27% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $228,295 +$180,608 +379% 31 Dec 2023 10-K 27 Mar 2025 2024 FY
Q3 2023 $268,637 +$185,719 +224% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 $308,251 +$190,552 +162% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 $255,320 +$103,286 +68% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 $47,687 -$138,256 -74% 31 Dec 2022 10-K 27 Mar 2025 2024 FY
Q3 2022 $82,918 -$136,513 -62% 30 Sep 2022 10-Q 07 Nov 2022 2022 Q3
Q2 2022 $117,699 -$134,804 -53% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 $152,034 31 Mar 2022 10-Q 03 May 2022 2022 Q1
Q4 2021 $185,943 31 Dec 2021 10-K 18 Mar 2024 2023 FY
Q3 2021 $219,431 30 Sep 2021 10-Q 01 Nov 2021 2021 Q3
Q2 2021 $252,503 30 Jun 2021 10-Q 29 Jul 2021 2021 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.